Main Article Content


This brief analyses the regulatory, security and ethical challenges facing states and the international community regarding emerging technologies in biotechnology, focusing on the CRISPR/Cas9 gene editing system and artificial gene synthesis. It highlights the inadequacy of current mechanisms such as export control regimes to regulate these emerging technologies because of a fundamental shift in the nature of challenges posed and an altered global landscape. The brief also underlines the need for an inclusive mechanism to facilitate discussions on the ethical issues, and suggests possible solutions to the manifold dilemma.


the CRISPR/Cas9 artificial gene synthesis Regulatory Security and Ethical challenges

Article Details